Global Viral Vectors Market Size, Status and Forecast 2020-2026

August 2020 | 126 pages | ID: GEE116326144EN
QYResearch

Abstracts

This report focuses on the global Viral Vectors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Viral Vectors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• BioReliance
• Cobra Biologics
• Oxford BioMedica
• UniQure
• FinVector
• MolMed
• MassBiologics
• Richter-Helm
• FUJIFILM Diosynth Biotechnologies
• Lonza
• Aldevron
• Eurogentec
• Cell and Gene Therapy Catapult
• Biovian
• Brammer Bio
• VGXI
• PlasmidFactory

Market segment by Type, the product can be split into

• Retroviral Vectors
• Lentiviral Vectors
• Adenoviral Vectors
• Herpes Simplex Virus Vectors
• Chimeric Viral Vectors
• Others

Market segment by Application, split into

• Cancers
• Inherited Disorders
• Viral Infections
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Viral Vectors status, future forecast, growth opportunity, key market and key players.
• To present the Viral Vectors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Viral Vectors are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Viral Vectors Revenue
1.4 Market Analysis by Type
  1.4.1 Global Viral Vectors Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Retroviral Vectors
  1.4.3 Lentiviral Vectors
  1.4.4 Adenoviral Vectors
  1.4.5 Herpes Simplex Virus Vectors
  1.4.6 Chimeric Viral Vectors
  1.4.7 Others
1.5 Market by Application
  1.5.1 Global Viral Vectors Market Share by Application: 2020 VS 2026
  1.5.2 Cancers
  1.5.3 Inherited Disorders
  1.5.4 Viral Infections
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Viral Vectors Industry Impact
  1.6.1 How the Covid-19 is Affecting the Viral Vectors Industry
    1.6.1.1 Viral Vectors Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Viral Vectors Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Viral Vectors Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Viral Vectors Market Perspective (2015-2026)
2.2 Viral Vectors Growth Trends by Regions
  2.2.1 Viral Vectors Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Viral Vectors Historic Market Share by Regions (2015-2020)
  2.2.3 Viral Vectors Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Viral Vectors Market Growth Strategy
  2.3.6 Primary Interviews with Key Viral Vectors Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Viral Vectors Players by Market Size
  3.1.1 Global Top Viral Vectors Players by Revenue (2015-2020)
  3.1.2 Global Viral Vectors Revenue Market Share by Players (2015-2020)
  3.1.3 Global Viral Vectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Viral Vectors Market Concentration Ratio
  3.2.1 Global Viral Vectors Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Viral Vectors Revenue in 2019
3.3 Viral Vectors Key Players Head office and Area Served
3.4 Key Players Viral Vectors Product Solution and Service
3.5 Date of Enter into Viral Vectors Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Viral Vectors Historic Market Size by Type (2015-2020)
4.2 Global Viral Vectors Forecasted Market Size by Type (2021-2026)

5 VIRAL VECTORS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Viral Vectors Market Size by Application (2015-2020)
5.2 Global Viral Vectors Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Viral Vectors Market Size (2015-2020)
6.2 Viral Vectors Key Players in North America (2019-2020)
6.3 North America Viral Vectors Market Size by Type (2015-2020)
6.4 North America Viral Vectors Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Viral Vectors Market Size (2015-2020)
7.2 Viral Vectors Key Players in Europe (2019-2020)
7.3 Europe Viral Vectors Market Size by Type (2015-2020)
7.4 Europe Viral Vectors Market Size by Application (2015-2020)

8 CHINA

8.1 China Viral Vectors Market Size (2015-2020)
8.2 Viral Vectors Key Players in China (2019-2020)
8.3 China Viral Vectors Market Size by Type (2015-2020)
8.4 China Viral Vectors Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Viral Vectors Market Size (2015-2020)
9.2 Viral Vectors Key Players in Japan (2019-2020)
9.3 Japan Viral Vectors Market Size by Type (2015-2020)
9.4 Japan Viral Vectors Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Viral Vectors Market Size (2015-2020)
10.2 Viral Vectors Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Viral Vectors Market Size by Type (2015-2020)
10.4 Southeast Asia Viral Vectors Market Size by Application (2015-2020)

11 INDIA

11.1 India Viral Vectors Market Size (2015-2020)
11.2 Viral Vectors Key Players in India (2019-2020)
11.3 India Viral Vectors Market Size by Type (2015-2020)
11.4 India Viral Vectors Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Viral Vectors Market Size (2015-2020)
12.2 Viral Vectors Key Players in Central & South America (2019-2020)
12.3 Central & South America Viral Vectors Market Size by Type (2015-2020)
12.4 Central & South America Viral Vectors Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 BioReliance
  13.1.1 BioReliance Company Details
  13.1.2 BioReliance Business Overview and Its Total Revenue
  13.1.3 BioReliance Viral Vectors Introduction
  13.1.4 BioReliance Revenue in Viral Vectors Business (2015-2020))
  13.1.5 BioReliance Recent Development
13.2 Cobra Biologics
  13.2.1 Cobra Biologics Company Details
  13.2.2 Cobra Biologics Business Overview and Its Total Revenue
  13.2.3 Cobra Biologics Viral Vectors Introduction
  13.2.4 Cobra Biologics Revenue in Viral Vectors Business (2015-2020)
  13.2.5 Cobra Biologics Recent Development
13.3 Oxford BioMedica
  13.3.1 Oxford BioMedica Company Details
  13.3.2 Oxford BioMedica Business Overview and Its Total Revenue
  13.3.3 Oxford BioMedica Viral Vectors Introduction
  13.3.4 Oxford BioMedica Revenue in Viral Vectors Business (2015-2020)
  13.3.5 Oxford BioMedica Recent Development
13.4 UniQure
  13.4.1 UniQure Company Details
  13.4.2 UniQure Business Overview and Its Total Revenue
  13.4.3 UniQure Viral Vectors Introduction
  13.4.4 UniQure Revenue in Viral Vectors Business (2015-2020)
  13.4.5 UniQure Recent Development
13.5 FinVector
  13.5.1 FinVector Company Details
  13.5.2 FinVector Business Overview and Its Total Revenue
  13.5.3 FinVector Viral Vectors Introduction
  13.5.4 FinVector Revenue in Viral Vectors Business (2015-2020)
  13.5.5 FinVector Recent Development
13.6 MolMed
  13.6.1 MolMed Company Details
  13.6.2 MolMed Business Overview and Its Total Revenue
  13.6.3 MolMed Viral Vectors Introduction
  13.6.4 MolMed Revenue in Viral Vectors Business (2015-2020)
  13.6.5 MolMed Recent Development
13.7 MassBiologics
  13.7.1 MassBiologics Company Details
  13.7.2 MassBiologics Business Overview and Its Total Revenue
  13.7.3 MassBiologics Viral Vectors Introduction
  13.7.4 MassBiologics Revenue in Viral Vectors Business (2015-2020)
  13.7.5 MassBiologics Recent Development
13.8 Richter-Helm
  13.8.1 Richter-Helm Company Details
  13.8.2 Richter-Helm Business Overview and Its Total Revenue
  13.8.3 Richter-Helm Viral Vectors Introduction
  13.8.4 Richter-Helm Revenue in Viral Vectors Business (2015-2020)
  13.8.5 Richter-Helm Recent Development
13.9 FUJIFILM Diosynth Biotechnologies
  13.9.1 FUJIFILM Diosynth Biotechnologies Company Details
  13.9.2 FUJIFILM Diosynth Biotechnologies Business Overview and Its Total Revenue
  13.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors Introduction
  13.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors Business (2015-2020)
  13.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
13.10 Lonza
  13.10.1 Lonza Company Details
  13.10.2 Lonza Business Overview and Its Total Revenue
  13.10.3 Lonza Viral Vectors Introduction
  13.10.4 Lonza Revenue in Viral Vectors Business (2015-2020)
  13.10.5 Lonza Recent Development
13.11 Aldevron
  10.11.1 Aldevron Company Details
  10.11.2 Aldevron Business Overview and Its Total Revenue
  10.11.3 Aldevron Viral Vectors Introduction
  10.11.4 Aldevron Revenue in Viral Vectors Business (2015-2020)
  10.11.5 Aldevron Recent Development
13.12 Eurogentec
  10.12.1 Eurogentec Company Details
  10.12.2 Eurogentec Business Overview and Its Total Revenue
  10.12.3 Eurogentec Viral Vectors Introduction
  10.12.4 Eurogentec Revenue in Viral Vectors Business (2015-2020)
  10.12.5 Eurogentec Recent Development
13.13 Cell and Gene Therapy Catapult
  10.13.1 Cell and Gene Therapy Catapult Company Details
  10.13.2 Cell and Gene Therapy Catapult Business Overview and Its Total Revenue
  10.13.3 Cell and Gene Therapy Catapult Viral Vectors Introduction
  10.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vectors Business (2015-2020)
  10.13.5 Cell and Gene Therapy Catapult Recent Development
13.14 Biovian
  10.14.1 Biovian Company Details
  10.14.2 Biovian Business Overview and Its Total Revenue
  10.14.3 Biovian Viral Vectors Introduction
  10.14.4 Biovian Revenue in Viral Vectors Business (2015-2020)
  10.14.5 Biovian Recent Development
13.15 Brammer Bio
  10.15.1 Brammer Bio Company Details
  10.15.2 Brammer Bio Business Overview and Its Total Revenue
  10.15.3 Brammer Bio Viral Vectors Introduction
  10.15.4 Brammer Bio Revenue in Viral Vectors Business (2015-2020)
  10.15.5 Brammer Bio Recent Development
13.16 VGXI
  10.16.1 VGXI Company Details
  10.16.2 VGXI Business Overview and Its Total Revenue
  10.16.3 VGXI Viral Vectors Introduction
  10.16.4 VGXI Revenue in Viral Vectors Business (2015-2020)
  10.16.5 VGXI Recent Development
13.17 PlasmidFactory
  10.17.1 PlasmidFactory Company Details
  10.17.2 PlasmidFactory Business Overview and Its Total Revenue
  10.17.3 PlasmidFactory Viral Vectors Introduction
  10.17.4 PlasmidFactory Revenue in Viral Vectors Business (2015-2020)
  10.17.5 PlasmidFactory Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Viral Vectors Key Market Segments
Table 2. Key Players Covered: Ranking by Viral Vectors Revenue
Table 3. Ranking of Global Top Viral Vectors Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Viral Vectors Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Retroviral Vectors
Table 6. Key Players of Lentiviral Vectors
Table 7. Key Players of Adenoviral Vectors
Table 8. Key Players of Herpes Simplex Virus Vectors
Table 9. Key Players of Chimeric Viral Vectors
Table 10. Key Players of Others
Table 11. COVID-19 Impact Global Market: (Four Viral Vectors Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for Viral Vectors Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for Viral Vectors Players to Combat Covid-19 Impact
Table 16. Global Viral Vectors Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 17. Global Viral Vectors Market Size by Regions (US$ Million): 2020 VS 2026
Table 18. Global Viral Vectors Market Size by Regions (2015-2020) (US$ Million)
Table 19. Global Viral Vectors Market Share by Regions (2015-2020)
Table 20. Global Viral Vectors Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 21. Global Viral Vectors Market Share by Regions (2021-2026)
Table 22. Market Top Trends
Table 23. Key Drivers: Impact Analysis
Table 24. Key Challenges
Table 25. Viral Vectors Market Growth Strategy
Table 26. Main Points Interviewed from Key Viral Vectors Players
Table 27. Global Viral Vectors Revenue by Players (2015-2020) (Million US$)
Table 28. Global Viral Vectors Market Share by Players (2015-2020)
Table 29. Global Top Viral Vectors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vectors as of 2019)
Table 30. Global Viral Vectors by Players Market Concentration Ratio (CR5 and HHI)
Table 31. Key Players Headquarters and Area Served
Table 32. Key Players Viral Vectors Product Solution and Service
Table 33. Date of Enter into Viral Vectors Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Viral Vectors Market Size by Type (2015-2020) (Million US$)
Table 36. Global Viral Vectors Market Size Share by Type (2015-2020)
Table 37. Global Viral Vectors Revenue Market Share by Type (2021-2026)
Table 38. Global Viral Vectors Market Size Share by Application (2015-2020)
Table 39. Global Viral Vectors Market Size by Application (2015-2020) (Million US$)
Table 40. Global Viral Vectors Market Size Share by Application (2021-2026)
Table 41. North America Key Players Viral Vectors Revenue (2019-2020) (Million US$)
Table 42. North America Key Players Viral Vectors Market Share (2019-2020)
Table 43. North America Viral Vectors Market Size by Type (2015-2020) (Million US$)
Table 44. North America Viral Vectors Market Share by Type (2015-2020)
Table 45. North America Viral Vectors Market Size by Application (2015-2020) (Million US$)
Table 46. North America Viral Vectors Market Share by Application (2015-2020)
Table 47. Europe Key Players Viral Vectors Revenue (2019-2020) (Million US$)
Table 48. Europe Key Players Viral Vectors Market Share (2019-2020)
Table 49. Europe Viral Vectors Market Size by Type (2015-2020) (Million US$)
Table 50. Europe Viral Vectors Market Share by Type (2015-2020)
Table 51. Europe Viral Vectors Market Size by Application (2015-2020) (Million US$)
Table 52. Europe Viral Vectors Market Share by Application (2015-2020)
Table 53. China Key Players Viral Vectors Revenue (2019-2020) (Million US$)
Table 54. China Key Players Viral Vectors Market Share (2019-2020)
Table 55. China Viral Vectors Market Size by Type (2015-2020) (Million US$)
Table 56. China Viral Vectors Market Share by Type (2015-2020)
Table 57. China Viral Vectors Market Size by Application (2015-2020) (Million US$)
Table 58. China Viral Vectors Market Share by Application (2015-2020)
Table 59. Japan Key Players Viral Vectors Revenue (2019-2020) (Million US$)
Table 60. Japan Key Players Viral Vectors Market Share (2019-2020)
Table 61. Japan Viral Vectors Market Size by Type (2015-2020) (Million US$)
Table 62. Japan Viral Vectors Market Share by Type (2015-2020)
Table 63. Japan Viral Vectors Market Size by Application (2015-2020) (Million US$)
Table 64. Japan Viral Vectors Market Share by Application (2015-2020)
Table 65. Southeast Asia Key Players Viral Vectors Revenue (2019-2020) (Million US$)
Table 66. Southeast Asia Key Players Viral Vectors Market Share (2019-2020)
Table 67. Southeast Asia Viral Vectors Market Size by Type (2015-2020) (Million US$)
Table 68. Southeast Asia Viral Vectors Market Share by Type (2015-2020)
Table 69. Southeast Asia Viral Vectors Market Size by Application (2015-2020) (Million US$)
Table 70. Southeast Asia Viral Vectors Market Share by Application (2015-2020)
Table 71. India Key Players Viral Vectors Revenue (2019-2020) (Million US$)
Table 72. India Key Players Viral Vectors Market Share (2019-2020)
Table 73. India Viral Vectors Market Size by Type (2015-2020) (Million US$)
Table 74. India Viral Vectors Market Share by Type (2015-2020)
Table 75. India Viral Vectors Market Size by Application (2015-2020) (Million US$)
Table 76. India Viral Vectors Market Share by Application (2015-2020)
Table 77. Central & South America Key Players Viral Vectors Revenue (2019-2020) (Million US$)
Table 78. Central & South America Key Players Viral Vectors Market Share (2019-2020)
Table 79. Central & South America Viral Vectors Market Size by Type (2015-2020) (Million US$)
Table 80. Central & South America Viral Vectors Market Share by Type (2015-2020)
Table 81. Central & South America Viral Vectors Market Size by Application (2015-2020) (Million US$)
Table 82. Central & South America Viral Vectors Market Share by Application (2015-2020)
Table 83. BioReliance Company Details
Table 84. BioReliance Business Overview
Table 85. BioReliance Product
Table 86. BioReliance Revenue in Viral Vectors Business (2015-2020) (Million US$)
Table 87. BioReliance Recent Development
Table 88. Cobra Biologics Company Details
Table 89. Cobra Biologics Business Overview
Table 90. Cobra Biologics Product
Table 91. Cobra Biologics Revenue in Viral Vectors Business (2015-2020) (Million US$)
Table 92. Cobra Biologics Recent Development
Table 93. Oxford BioMedica Company Details
Table 94. Oxford BioMedica Business Overview
Table 95. Oxford BioMedica Product
Table 96. Oxford BioMedica Revenue in Viral Vectors Business (2015-2020) (Million US$)
Table 97. Oxford BioMedica Recent Development
Table 98. UniQure Company Details
Table 99. UniQure Business Overview
Table 100. UniQure Product
Table 101. UniQure Revenue in Viral Vectors Business (2015-2020) (Million US$)
Table 102. UniQure Recent Development
Table 103. FinVector Company Details
Table 104. FinVector Business Overview
Table 105. FinVector Product
Table 106. FinVector Revenue in Viral Vectors Business (2015-2020) (Million US$)
Table 107. FinVector Recent Development
Table 108. MolMed Company Details
Table 109. MolMed Business Overview
Table 110. MolMed Product
Table 111. MolMed Revenue in Viral Vectors Business (2015-2020) (Million US$)
Table 112. MolMed Recent Development
Table 113. MassBiologics Company Details
Table 114. MassBiologics Business Overview
Table 115. MassBiologics Product
Table 116. MassBiologics Revenue in Viral Vectors Business (2015-2020) (Million US$)
Table 117. MassBiologics Recent Development
Table 118. Richter-Helm Business Overview
Table 119. Richter-Helm Product
Table 120. Richter-Helm Company Details
Table 121. Richter-Helm Revenue in Viral Vectors Business (2015-2020) (Million US$)
Table 122. Richter-Helm Recent Development
Table 123. FUJIFILM Diosynth Biotechnologies Company Details
Table 124. FUJIFILM Diosynth Biotechnologies Business Overview
Table 125. FUJIFILM Diosynth Biotechnologies Product
Table 126. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors Business (2015-2020) (Million US$)
Table 127. FUJIFILM Diosynth Biotechnologies Recent Development
Table 128. Lonza Company Details
Table 129. Lonza Business Overview
Table 130. Lonza Product
Table 131. Lonza Revenue in Viral Vectors Business (2015-2020) (Million US$)
Table 132. Lonza Recent Development
Table 133. Aldevron Company Details
Table 134. Aldevron Business Overview
Table 135. Aldevron Product
Table 136. Aldevron Revenue in Viral Vectors Business (2015-2020) (Million US$)
Table 137. Aldevron Recent Development
Table 138. Eurogentec Company Details
Table 139. Eurogentec Business Overview
Table 140. Eurogentec Product
Table 141. Eurogentec Revenue in Viral Vectors Business (2015-2020) (Million US$)
Table 142. Eurogentec Recent Development
Table 143. Cell and Gene Therapy Catapult Company Details
Table 144. Cell and Gene Therapy Catapult Business Overview
Table 145. Cell and Gene Therapy Catapult Product
Table 146. Cell and Gene Therapy Catapult Revenue in Viral Vectors Business (2015-2020) (Million US$)
Table 147. Cell and Gene Therapy Catapult Recent Development
Table 148. Biovian Company Details
Table 149. Biovian Business Overview
Table 150. Biovian Product
Table 151. Biovian Revenue in Viral Vectors Business (2015-2020) (Million US$)
Table 152. Biovian Recent Development
Table 153. Brammer Bio Company Details
Table 154. Brammer Bio Business Overview
Table 155. Brammer Bio Product
Table 156. Brammer Bio Revenue in Viral Vectors Business (2015-2020) (Million US$)
Table 157. Brammer Bio Recent Development
Table 158. VGXI Company Details
Table 159. VGXI Business Overview
Table 160. VGXI Product
Table 161. VGXI Revenue in Viral Vectors Business (2015-2020) (Million US$)
Table 162. VGXI Recent Development
Table 163. PlasmidFactory Company Details
Table 164. PlasmidFactory Business Overview
Table 165. PlasmidFactory Product
Table 166. PlasmidFactory Revenue in Viral Vectors Business (2015-2020) (Million US$)
Table 167. PlasmidFactory Recent Development
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Viral Vectors Market Share by Type: 2020 VS 2026
Figure 2. Retroviral Vectors Features
Figure 3. Lentiviral Vectors Features
Figure 4. Adenoviral Vectors Features
Figure 5. Herpes Simplex Virus Vectors Features
Figure 6. Chimeric Viral Vectors Features
Figure 7. Others Features
Figure 8. Global Viral Vectors Market Share by Application: 2020 VS 2026
Figure 9. Cancers Case Studies
Figure 10. Inherited Disorders Case Studies
Figure 11. Viral Infections Case Studies
Figure 12. Others Case Studies
Figure 13. Viral Vectors Report Years Considered
Figure 14. Global Viral Vectors Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Viral Vectors Market Share by Regions: 2020 VS 2026
Figure 16. Global Viral Vectors Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Viral Vectors Market Share by Players in 2019
Figure 19. Global Top Viral Vectors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vectors as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Viral Vectors Revenue in 2019
Figure 21. North America Viral Vectors Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Viral Vectors Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Viral Vectors Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Viral Vectors Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Viral Vectors Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Viral Vectors Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Viral Vectors Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. BioReliance Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. BioReliance Revenue Growth Rate in Viral Vectors Business (2015-2020)
Figure 30. Cobra Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Cobra Biologics Revenue Growth Rate in Viral Vectors Business (2015-2020)
Figure 32. Oxford BioMedica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Oxford BioMedica Revenue Growth Rate in Viral Vectors Business (2015-2020)
Figure 34. UniQure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. UniQure Revenue Growth Rate in Viral Vectors Business (2015-2020)
Figure 36. FinVector Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. FinVector Revenue Growth Rate in Viral Vectors Business (2015-2020)
Figure 38. MolMed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. MolMed Revenue Growth Rate in Viral Vectors Business (2015-2020)
Figure 40. MassBiologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. MassBiologics Revenue Growth Rate in Viral Vectors Business (2015-2020)
Figure 42. Richter-Helm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Richter-Helm Revenue Growth Rate in Viral Vectors Business (2015-2020)
Figure 44. FUJIFILM Diosynth Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vectors Business (2015-2020)
Figure 46. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Lonza Revenue Growth Rate in Viral Vectors Business (2015-2020)
Figure 48. Aldevron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Aldevron Revenue Growth Rate in Viral Vectors Business (2015-2020)
Figure 50. Eurogentec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Eurogentec Revenue Growth Rate in Viral Vectors Business (2015-2020)
Figure 52. Cell and Gene Therapy Catapult Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vectors Business (2015-2020)
Figure 54. Biovian Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Biovian Revenue Growth Rate in Viral Vectors Business (2015-2020)
Figure 56. Brammer Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Brammer Bio Revenue Growth Rate in Viral Vectors Business (2015-2020)
Figure 58. VGXI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. VGXI Revenue Growth Rate in Viral Vectors Business (2015-2020)
Figure 60. PlasmidFactory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. PlasmidFactory Revenue Growth Rate in Viral Vectors Business (2015-2020)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed